FIFTH THIRD BANCORP - HALOZYME THERAPEUTICS INC ownership

HALOZYME THERAPEUTICS INC's ticker is HALO and the CUSIP is 40637H109. A total of 316 filers reported holding HALOZYME THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.23 and the average weighting 0.2%.

Quarter-by-quarter ownership
FIFTH THIRD BANCORP ownership history of HALOZYME THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$468,408
+8.6%
12,262
+2.6%
0.00%0.0%
Q2 2023$431,181
+11.1%
11,954
+17.7%
0.00%0.0%
Q1 2023$387,972
-47.1%
10,159
-21.2%
0.00%
-50.0%
Q4 2022$733,157
+32.1%
12,885
-8.2%
0.00%
+33.3%
Q3 2022$555,000
-10.2%
14,035
-0.1%
0.00%0.0%
Q2 2022$618,000
+10.0%
14,044
-0.3%
0.00%
+50.0%
Q1 2022$562,000
+18.6%
14,092
+19.5%
0.00%0.0%
Q4 2021$474,000
+3.5%
11,793
+4.7%
0.00%0.0%
Q3 2021$458,000
-6.9%
11,259
+3.8%
0.00%0.0%
Q2 2021$492,000
+13.4%
10,842
+4.1%
0.00%0.0%
Q1 2021$434,000
+3.1%
10,412
+5.7%
0.00%0.0%
Q4 2020$421,000
+188.4%
9,854
+77.4%
0.00%
+100.0%
Q3 2020$146,000
+3550.0%
5,556
+4015.6%
0.00%
Q2 2020$4,000
+100.0%
1350.0%0.00%
Q1 2020$2,0000.0%1350.0%0.00%
Q4 2019$2,000
-94.3%
135
-93.2%
0.00%
Q3 2017$35,000
+34.6%
2,0000.0%0.00%
Q2 2017$26,0000.0%2,0000.0%0.00%
Q1 2017$26,000
+1200.0%
2,000
+900.0%
0.00%
Q3 2016$2,0002000.00%
Other shareholders
HALOZYME THERAPEUTICS INC shareholders Q1 2022
NameSharesValueWeighting ↓
Third Security, LLC 14,092,771$256,066,00016.64%
BB BIOTECH AG 8,247,860$149,864,0003.97%
MSD Partners, L.P. 2,245,000$40,792,0003.07%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 428,633$5,969,0002.84%
First Light Asset Management, LLC 885,523$16,090,0002.60%
SNYDER CAPITAL MANAGEMENT L P 2,387,350$43,378,0001.93%
Sterling Global Strategies LLC 22,000$400,0001.74%
Taylor Wealth Management Partners 221,380$4,022,0001.71%
IRIDIAN ASSET MANAGEMENT LLC/CT 9,228,399$167,680,0001.68%
DOHENY ASSET MANAGEMENT /CA 124,393$2,260,0001.18%
View complete list of HALOZYME THERAPEUTICS INC shareholders